Alarm fatigue is the desensitization that occurs when clinicians are exposed to a high volume of alarms, many of which are false or nonactionable. This can lead to slower responses or missed critical alerts, putting patients at risk in any monitoring environment. A practical way to mitigate it is to manage alarms effectively: set appropriate alarm limits so only clinically meaningful changes trigger alerts, prioritize and customize alarms to the specific patient and situation, and perform regular maintenance and sensor checks to reduce false or nonactionable alarms. By reducing nuisance alarms while preserving true emergencies, the monitoring system remains responsive and safer.

Normal serum potassium is about 3.5 to 5.0 mEq/L. Potassium primarily sits inside cells, and extracellular levels fine‑tune the resting membrane potential of excitable tissues such as nerves, skeletal muscle, and the heart. Small shifts outside this range can significantly affect how easily these tissues depolarize and conduct impulses. If potassium falls below 3.5, muscles can become weak and irregularities in cardiac rhythm may occur. If it rises above 5.0, the heart and nerves can become overly excitable or conduct abnormally, leading to dangerous rhythm problems. Clinically, labs may list a range that varies slightly (some say up to 5.5), but the commonly used normal range is 3.5–5.0 mEq/L. Also be aware that improper sample handling (like hemolysis) can falsely raise potassium readings.

Auto-PEEP is air trapping that happens when expiration is incomplete before the next breath starts, so positive pressure remains in the airways at the end of expiration. This intrinsic PEEP builds up on the ventilator when the expiratory time is too short, or airway resistance is high, or the respiratory rate is rapid. The result is dynamic hyperinflation, higher end-expiratory airway pressure, and can impair venous return and hemodynamics, with a risk of barotrauma. This description fits best because it emphasizes air trapping from incomplete expiration rather than any improvement in oxygenation, reduction in dead space, or decrease in airway resistance.

The key idea is that the Frank-Starling curve shows how much the heart can pump (stroke volume) for a given amount of filling (preload). The curve’s position is determined by contractility—the heart’s ability to generate force. When contractility falls, the ventricle can eject less blood for the same filling, so the entire curve shifts downward. Administering a beta-blocker reduces contractility (negative inotropy), so for any level of preload the stroke volume is lower, moving the curve downward. Increasing preload or moving along the curve simply changes the operating point along the same curve. A positive inotropic drug would raise the curve, increasing stroke volume at the same preload, while decreasing afterload alters the flow at a given preload but doesn’t shift the curve itself.